MENU
+Compare
SGRY
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$25.31
Change
-$0.36 (-1.40%)
Capitalization
3.66B

SGRY Surgery Partners Forecast, Technical & Fundamental Analysis

a company which engages in health care services

SGRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SGRY with price predictions
Feb 21, 2025

SGRY in downward trend: price expected to drop as it breaks its higher Bollinger Band on January 28, 2025

SGRY broke above its upper Bollinger Band on January 28, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 47 similar instances where the stock broke above the upper band. In of the 47 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for SGRY moved out of overbought territory on February 12, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 67 cases where SGRY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on February 20, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SGRY as a result. In of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SGRY turned negative on February 20, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SGRY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

SGRY moved above its 50-day moving average on January 28, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SGRY crossed bullishly above the 50-day moving average on January 30, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SGRY advanced for three days, in of 270 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 255 cases where SGRY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SGRY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SGRY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.840) is normal, around the industry mean (4.533). P/E Ratio (0.000) is within average values for comparable stocks, (71.885). SGRY's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.595). SGRY has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.026). P/S Ratio (1.322) is also within normal values, averaging (21.325).

View a ticker or compare two or three
SGRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SGRY is expected to report earnings to rise 102.84% to 38 cents per share on March 03

Surgery Partners SGRY Stock Earnings Reports
Q4'24
Est.
$0.39
Q3'24
Missed
by $0.06
Q2'24
Beat
by $0.01
Q1'24
Beat
by $0.02
Q4'23
Beat
by $0.06
The last earnings report on November 12 showed earnings per share of 18 cents, missing the estimate of 25 cents. With 1.34M shares outstanding, the current market capitalization sits at 3.66B.
A.I. Advisor
published General Information

General Information

a company which engages in health care services

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Hospital Or Nursing Management
Address
340 Seven Springs Way
Phone
+1 615 234-5900
Employees
13500
Web
https://www.surgerypartners.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RWMAX63.11-0.87
-1.36%
American Funds Washington Mutual R1
BRTNX73.73-1.40
-1.86%
Bretton Fund
FTRNX174.40-6.06
-3.36%
Fidelity Trend
MIDFX51.95-1.81
-3.37%
Marsico Midcap Growth Focus Instl
AGOZX20.01-0.96
-4.58%
Alger Small Cap Focus Z

SGRY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SGRY has been loosely correlated with USPH. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SGRY jumps, then USPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGRY
1D Price
Change %
SGRY100%
-1.40%
USPH - SGRY
42%
Loosely correlated
-2.16%
HCA - SGRY
40%
Loosely correlated
-1.58%
THC - SGRY
39%
Loosely correlated
-5.57%
UHS - SGRY
39%
Loosely correlated
-2.25%
SEM - SGRY
37%
Loosely correlated
-7.24%
More